About This Calculator
The Fidaxomicin Dose Calculator is a clinical support tool designed to determine the appropriate dosage of fidaxomicin (Dificid®) for treating Clostridioides difficile-associated diarrhea (CDAD). It provides dosing recommendations for both adult and pediatric patients based on weight, age, and the selected drug formulation (oral suspension or tablets), in line with the official prescribing information.
Outputs Explained
After entering the patient's information, the calculator will provide the following outputs:
- Recommended Dose: The precise dose in milligrams (mg) to be administered.
- Volume to Administer: For the oral suspension, the specific volume in milliliters (mL) corresponding to the calculated dose. The suspension's concentration is 40 mg/mL.
- Dosing Frequency: The standard frequency for fidaxomicin, which is twice daily (every 12 hours).
- Treatment Duration: The recommended course of therapy is 10 days.
- Safety Flags: The tool will display a warning if fidaxomicin is not recommended based on the patient's age or weight (e.g., patients under 6 months of age).
How to Use the Tool
To calculate the correct fidaxomicin dose, please follow these steps:
- Enter Patient Weight: Input the patient's weight and select the appropriate unit (kg or lbs).
- Enter Patient Age: Provide the patient's age in years and/or months. This is crucial for pediatric patients to ensure safety criteria are met.
- Select Formulation: Choose between the Oral Suspension (40 mg/mL) or Tablets (200 mg). The oral suspension is the required formulation for pediatric weight-based dosing. The tablet option will calculate the standard adult dose.
Dosing Overview
Fidaxomicin dosing varies between adults and pediatric patients.
Adults: The standard adult dose is one 200 mg tablet taken orally twice a day (every 12 hours) for 10 days.
Pediatric Patients (from 6 months of age): Dosing for the oral suspension (40 mg/mL) is based on body weight:
| Patient Body Weight | Dose (mg) | Volume of Suspension (mL) | Frequency & Duration |
|---|---|---|---|
| 4 kg to less than 7 kg | 80 mg | 2 mL | Twice daily for 10 days |
| 7 kg to less than 9 kg | 120 mg | 3 mL | |
| 9 kg to less than 12.5 kg | 160 mg | 4 mL | |
| 12.5 kg or more | 200 mg | 5 mL |
The oral suspension must be reconstituted by a pharmacist to a final concentration of 40 mg/mL before dispensing. It should be shaken well before each use and can be administered with or without food.
Switching Formulations
Pediatric patients who weigh at least 12.5 kg and are able to swallow tablets may be prescribed the 200 mg tablet instead of the oral suspension. The dose is the same: one 200 mg tablet twice daily for 10 days. This provides a convenient alternative to the oral liquid for appropriate patients.
Missed Dose Protocol
If a dose of fidaxomicin is missed, the patient or caregiver should be advised to administer it as soon as they remember. However, if it is almost time for the next scheduled dose, they should skip the missed dose and resume the normal dosing schedule. Instruct them not to take two doses at the same time to make up for a missed one.
Safety Alerts
- Age and Weight Restrictions: Fidaxomicin is not recommended for pediatric patients under 6 months of age or those weighing less than 4 kg, as its safety and effectiveness have not been established in this group.
- Hypersensitivity: Fidaxomicin is contraindicated in patients with a known hypersensitivity to the drug or any of its components.
- Renal and Hepatic Impairment: No dose adjustment is necessary for patients with renal or hepatic impairment due to fidaxomicin's minimal systemic absorption.
Frequently Asked Questions
Age is a critical safety check. The calculator uses the patient's age to flag if they are under 6 months, a population in which fidaxomicin is not recommended.
The calculator defaults to the standard adult dose of 200 mg, as tablets are not used for weight-based tiered dosing. This is suitable for adults and pediatric patients who can swallow tablets and weigh at least 12.5 kg.
After reconstitution by a pharmacist, the final concentration of the oral suspension is 40 mg/mL.
A child weighing 12.5 kg falls into the highest pediatric dosing tier (≥12.5 kg) and will receive a 200 mg (5 mL) dose.
No. This tool is specifically designed for dosing fidaxomicin in the treatment of C. difficile-associated diarrhea as per its approved indication.
The suspension should be shaken well before each dose. It can be given with or without food. An oral dosing syringe should be used to measure the correct volume accurately.
No. According to the prescribing information, fidaxomicin has very low absorption into the bloodstream, and dose adjustments are not required for patients with renal or hepatic impairment.
The standard course of treatment with fidaxomicin for C. difficile infection is 10 days.
References
- DIFICID® (fidaxomicin) Prescribing Information. U.S. Food and Drug Administration. Revised: 01/2023.
- DIFICID® (fidaxomicin) Official HCP Website. Merck & Co., Inc.
- Johnson S, Lavergne V, Skinner AM, et al. Clinical Practice Guideline for Clostridioides difficile Infection in Adults and Children: 2021 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clinical Infectious Diseases. 2021;73(5):e1029-e1044.
- Dificlir (fidaxomicin) Summary of Product Characteristics. European Medicines Agency.
I am a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. I hold a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research. With a strong academic foundation and practical knowledge, I am committed to providing accurate, easy-to-understand content to support pharmacy students and professionals. My aim is to make complex pharmaceutical concepts accessible and useful for real-world application.
Mail- Sachin@pharmacyfreak.com